| Literature DB >> 32967664 |
Jingke Xie1,2,3, Xingyun Huang1,3, Xia Wang1,4, Shixue Gou1,3, Yanhui Liang1,3, Fangbing Chen1,3, Nan Li1,2,3, Zhen Ouyang1,2,4, Quanjun Zhang1,2,4, Weikai Ge1,2,3, Qin Jin1,2,3, Hui Shi1,3, Zhenpeng Zhuang1,3, Xiaozhu Zhao1,3, Meng Lian1,5, Jiaowei Wang1,3, Yinghua Ye1,2,4, Longquan Quan1,2,4, Han Wu1,2,4, Kepin Wang6,7,8, Liangxue Lai9,10,11.
Abstract
BACKGROUND: Many favorable traits of crops and livestock and human genetic diseases arise from multiple single nucleotide polymorphisms or multiple point mutations with heterogeneous base substitutions at the same locus. Current cytosine or adenine base editors can only accomplish C-to-T (G-to-A) or A-to-G (T-to-C) substitutions in the windows of target genomic sites of organisms; therefore, there is a need to develop base editors that can simultaneously achieve C-to-T and A-to-G substitutions at the targeting site.Entities:
Keywords: Adenine and cytosine base editor (ACBE); Mammalian systems; Simultaneous C-to-T and A-to-G conversions
Mesh:
Substances:
Year: 2020 PMID: 32967664 PMCID: PMC7510086 DOI: 10.1186/s12915-020-00866-5
Source DB: PubMed Journal: BMC Biol ISSN: 1741-7007 Impact factor: 7.431
Fig. 1Simultaneous C-to-T and A-to-G base substitutions induced by the ACBE system. a Architectures of the dual-function base editing system, ACBE, and individual base editing systems, namely Target-AID and ABE7.10. ecTadAWT/*, a heterodimer of an evolved Escherichia coli TadA and a wild-type TadA; aa, amino acid; NLS, nuclear localization signal; UGI, inhibitor of uracil DNA glycosylase. b Schematic of the HEK293-EGFP reporter cell line and two targeting sgRNA (EGFP-Stop1 and EGFP-Stop2), which could induce a stop codon and mutation of start codon, respectively. c The representative results of flow cytometry showed the proportion of EGFP-negative cells edited by different base editors with the corresponding sgRNA. Three independent experiments were performed. d The representative Sanger sequencing results of the cell samples transfected with different base editors showed the target base substitutions in the targeting sites EGFP-Stop1 and EGFP-Stop2. The C-to-T and A-to-G substitutions were marked with red and black arrows, respectively. e The editing effects on the target site EGFP-Stop2 generated by the ACBE and CBE + ABE system. Different parts with various colors in the pie chart showed the frequencies of the corresponding mutation type
Fig. 2Base editing of ACBE in endogenous loci of HEK293 cells. a Summary of base editing type with ACBE at 45 sgRNAs targeting the human endogenous loci. b Average C-to-T and A-to-G base editing spectrum of ACBE for endogenous targeting sites in HEK293 cells based on the statistical analysis of the 45 sgRNAs. The values indicated the mean, and the untreated samples served as control. c The representative Sanger sequencing results of the cell samples transfected with different base editors showed the target base substitutions in the targeting sites P53-G7, P53-G8, LMNA-G1, LDHA-G1, and PGK1-G4. The C-to-T and A-to-G substitutions were marked with red and black arrows, respectively. Three independent experiments were performed. d The editing effects on the target sites P53-G7, P53-G8, LMNA-G1, LDHA-G1, and PGK1-G4 were generated by ACBE and CBE + ABE, respectively. Different parts with various colors in the pie chart showed the frequencies of the corresponding mutation type. The result was based on the representative amplicon deep sequencing (n = 3)
Fig. 3ACBE-mediated dual-function base editing in MEFs and PFFs. a The base editing effects of ACBE in mstn and tyr loci of MEFs; b The base editing effects of ACBE in TYR, FANCA, and LMNA loci of PFFs. The efficiencies of base editing (a, b) were quantified from amplicon deep sequencing. Values and error bars indicate mean ± s.e.m. of three independent experiments. An untreated cell sample served as control. c, d The efficiencies of ACBE-mediated simultaneous C-to-T and A-to-G base substitutions in the targeting loci of MEFs (c) and PFFs (d) were calculated the reads of amplicon deep sequencing. N.S., not significant (P > 0.05); *(0.05 > P ≥ 0.001); **(0.01 > P ≥ 0.0001); ***(P < 0.0001) (two-tailed t test)
Fig. 4ACBE-mediated base editing effects with different spacer lengths. a Schematic design for different spacer length of EGFP-Stop2. The red sequence indicated the PAM. b Flow cytometry results for testing different spacer lengths of EGFP-Stop2, n = 3. Untreated cell samples served as control. c, d The sequences represented the serial sgRNAs with different spacer lengths at P53-G8 (c) and P53-G9 (d) loci. The red sequence indicated the PAM. e, f Summary of ACBE-mediated base editing patterns and efficiencies of all C and A in P53-G8 (e) and P53-G9 (f) sites using sgRNAs with different spacer lengths. All values and error bars above indicate mean ± s.e.m. of three independent experiments. The controls were untreated cell samples. g, h The frequencies of simultaneous A > G and C > T mutation for P53-G8 (g) and P53-G9 (h) loci with different spacer length gRNA
Fig. 5ACBE-mediated base editing effects with different lengths of the linker peptides. a Schematic representation of ACBE, ACBE-0C, ACBE-20C, ACBE-16N, and ACBE-48 N architecture. The red square frame indicated the change of linkers. b Summary of flow cytometry results of HEK293-EGFP cells transfected ACBE variants with EGFP-Stop1 and EGFP-Stop2. c, d Summary of ACBE variants-mediated base editing patterns and efficiencies of all C and A in P53-G7 (c) and P53-G8 (d) targeting sites. e, f Summary of ACBE-mediated simbase editing patterns and efficiencies of all C and A in P53-G7 (e) and P53-G8 (f) sites using sgRNAs with different spacer lengths. The abovementioned values and error bars indicate mean ± s.e.m. of three independent experiments. The controls were untreated cell samples